TABLE I.
CsA CE, n | Vehicle, n | |
---|---|---|
Planned responder analyses | ||
In patients with moderate to severe DED | 241 | 248 |
Ocular discomfort responders = ≥25% improvement in VAS | ||
Complete responders = CFS score of 0 | ||
Post hoc responder analyses | ||
In patients with CFS score ≥3 and OSDI score ≥23 at baseline | 128 | 118 |
CFS responders = ≥2 grades improvement | ||
OSDI responders = ≥30% improvement | ||
Co-responders = improvement of ≥2 grades in CFS and ≥30% in OSDI | ||
In patients with CFS score of 4 at baseline | 43 | 42 |
CFS responders = ≥2 grades improvement | ||
Co-responders = improvement of ≥2 grades in CFS and ≥30% in OSDI | ||
In patients with CFS score of 2 at baseline | 83 | 93 |
Complete responders = CFS score of 0 |
N reflects the number of patients included in the full analysis set.
CsA CE = 0.1% cyclosporine A cationic emulsion; CFS = corneal fluorescein staining; DED = dry eye disease; OSDI = ocular surface disease index; VAS = visual analogue scale.